Viemed Healthcare (NASDAQ:VMD) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Viemed Healthcare (NASDAQ:VMD) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

A number of other research analysts have also recently weighed in on the stock. Weiss Ratings cut shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. Freedom Capital lowered shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 5th. Finally, Barrington Research started coverage on shares of Viemed Healthcare in a report on Monday, August 24th. They issued an “outperform” rating and a $14.00 target price for the company. One equities research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $12.00.

Viemed Healthcare Trading Down 2.0%

Shares of NASDAQ VMD opened at $8.95 on Friday. The business’s 50 day moving average is $9.26 and its two-hundred day moving average is $9.60. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.02. Viemed Healthcare has a 1-year low of $6.18 and a 1-year high of $12.61. The stock has a market capitalization of $340.91 million, a P/E ratio of 26.60, a PEG ratio of 2.45 and a beta of 1.05.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The company had revenue of $80.67 million during the quarter, compared to the consensus estimate of $80.78 million. Viemed Healthcare had a net margin of 5.03% and a return on equity of 10.77%. As a group, research analysts expect that Viemed Healthcare will post 0.41 EPS for the current year.

Hedge Funds Weigh In On Viemed Healthcare

A number of institutional investors have recently modified their holdings of VMD. Bank of America Corp DE purchased a new stake in Viemed Healthcare in the second quarter worth about $1,810,000. Nantahala Capital Management LLC purchased a new position in Viemed Healthcare during the 2nd quarter valued at about $7,209,873. Raffles Associates LP purchased a new position in Viemed Healthcare during the 2nd quarter valued at about $4,602,000. Punch & Associates Investment Management Inc. bought a new stake in shares of Viemed Healthcare in the 2nd quarter valued at about $6,082,000. Finally, BlackRock Inc. bought a new stake in shares of Viemed Healthcare in the 2nd quarter valued at about $54,587,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.